Sunev Pharma Solutions Limited

Sunev Pharma Solutions Limited - pharma in Chandigarh, Chandigarh, India. FY 2026 financials and compliance.
CIN U24232CH2006PLC030653 Incorporated 26 December 2006 ROC Chandigarh HQ Chandigarh, Chandigarh, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹30.03 Cr
▲ 100.00% YoY
EBITDA · FY 2025
*****
▲ 100.00% YoY
Net profit · FY 2025
*****
▲ 122.00% YoY
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹46.16 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹19.5 Cr
Company age
20 yrs
Est. 2006
Last financials
Mar 2025
Balance sheet date

About Sunev Pharma Solutions Limited

Data last updated: 06 January 2026

Sunev Pharma Solutions Limited is a public limited company based in Chandigarh, Chandigarh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 December 2006, the company has been in operation for over 20 years.

Registered with ROC Chandigarh under CIN U24232CH2006PTC030653.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹46.16 Lakh. It is led by directors including Manu Chaudhary and Ashutosh Jain.

Last AGM: 10 November 2025. Financial statements filed for year ended 31 March 2025. Office: Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101.

As per the financials filed for FY 2025, the company reported a revenue of ₹30.03 Cr, a growth of 100% compared to the previous year.

As per MCA filings, the company has satisfied charges of ₹19.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Sunev Pharma Solutions Limited
CIN U24232CH2006PLC030653
Registration Number 030653
Incorporation Date 26 December 2006
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 November 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Manu Chaudhary Director Ashutosh Jain Director Pawan Chaudhary Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Sunev Pharma Solutions Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sunev Pharma Solutions Limited report

Financials, compliance, directors, charges, ownership and filings for Sunev Pharma Solutions Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sunev Pharma Solutions Limited

Sunev Pharma Solutions Limited has one previous CIN (Corporate Identification Number): U24232CH2006PTC030653. The current CIN is U24232CH2006PLC030653, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232CH2006PLC030653 Current
U24232CH2006PTC030653 Previous

Business Activity of Sunev Pharma Solutions Limited

Sunev Pharma Solutions Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********

Board of Directors of Sunev Pharma Solutions Limited

Sunev Pharma Solutions Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Manu Chaudhary
Also directs: Venus Remedies Limited
Director 26 Dec 2006 19 Years 6 Months Current
Ashutosh Jain
Also directs: Venus Remedies Limited
Director 02 Jan 2007 19 Years 6 Months Current
Pawan Chaudhary
Also directs: Venus Remedies Limited, Spine Software Systems Private Limited
Director 26 Dec 2006 19 Years 6 Months Current
View all directors

Financials of Sunev Pharma Solutions Limited FY 2025 filings available

Sunev Pharma Solutions Limited reported revenue of ₹30.03 Cr (up 100% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹30.03 Cr ▲ 100%
Profit
***** ▲ 122%
EBITDA
***** ▲ 100%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Sunev Pharma Solutions Limited

Open charges
₹0
Satisfied charges
₹19.5 Cr
Breakdown by lending institutions
Dena Bank₹14.50 Cr
Allahabad Bank₹5.00 Cr
Latest charge details
DateLenderAmountStatus
26 Nov 2013 Dena Bank ₹14.5 Cr Satisfied
12 Oct 2010 Allahabad Bank ₹3.5 Cr Satisfied
12 Oct 2010 Allahabad Bank ₹1.5 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Sunev Pharma Solutions Limited

View historical data on people associated with Sunev Pharma Solutions Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sunev Pharma Solutions Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sunev Pharma Solutions Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sunev Pharma Solutions Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sunev Pharma Solutions Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sunev Pharma Solutions Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sunev Pharma Solutions Limited

MSME Payment Delays by Sunev Pharma Solutions Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sunev Pharma Solutions Limited

Subsidiaries & Group Companies of Sunev Pharma Solutions Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sunev Pharma Solutions Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sunev Pharma Solutions Limited

MCA Filings & Documents of Sunev Pharma Solutions Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sunev Pharma Solutions Limited

Activity
10 Nov 2025
Sunev Pharma Solutions Limited last Annual general meeting of members was held on 10 Nov 2025 as per latest MCA records.
Activity
31 Mar 2025
Sunev Pharma Solutions Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
07 Aug 2020
A charge registered on 26 Nov 2013 via Charge ID 10462274 with Dena Bank was fully satisfied on 07 Aug 2020.
Charges
27 Nov 2018
A charge registered on 12 Oct 2010 via Charge ID 10250471 with Allahabad Bank was fully satisfied on 27 Nov 2018.
Charges
27 Nov 2018
A charge registered on 12 Oct 2010 via Charge ID 10250473 with Allahabad Bank was fully satisfied on 27 Nov 2018.
Charges
26 Nov 2013
A charge with Dena Bank amounted to Rs. 1,450.00 Lakh with Charge ID 10462274 was registered on 26 Nov 2013.

Frequently Asked Questions about Sunev Pharma Solutions Limited

Sunev Pharma Solutions Limited is an active public limited company in the pharma sector based in Chandigarh, Chandigarh, India. It was incorporated on 26 December 2006 (20+ years old) and is registered under CIN U24232CH2006PLC030653.

Sunev Pharma Solutions Limited reported revenue of ₹30.03 Cr for FY 2025 (up 100.00% YoY).

The current directors of Sunev Pharma Solutions Limited are:

The primary industry of Sunev Pharma Solutions Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Sunev Pharma Solutions Limited can be reached at the registered office: Sco 857 2Nd Floor C. No. 10 Nac Manimajra, Chandigarh, Chandigarh, India – 160101.

The authorised capital is ₹50 Lakh, and the paid-up capital is ₹46.16 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available